ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 99 filers reported holding ABEONA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $21,000 | -83.3% | 11,318 | -81.2% | 0.00% | – |
Q1 2020 | $126,000 | -91.9% | 60,133 | -50.7% | 0.00% | – |
Q3 2018 | $1,562,000 | -23.4% | 122,032 | -4.2% | 0.00% | -100.0% |
Q2 2018 | $2,039,000 | -40.3% | 127,447 | -40.9% | 0.00% | 0.0% |
Q4 2017 | $3,415,000 | +4578.1% | 215,467 | +1778.7% | 0.00% | – |
Q2 2017 | $73,000 | +17.7% | 11,469 | -7.6% | 0.00% | – |
Q1 2017 | $62,000 | +1450.0% | 12,414 | +1440.2% | 0.00% | – |
Q2 2015 | $4,000 | – | 806 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,359,767 | $3,209,000 | 1.04% |
DAFNA Capital Management LLC | 181,818 | $429,000 | 0.34% |
Perceptive Advisors | 1,762,881 | $4,159,000 | 0.29% |
NEXTHERA CAPITAL LP | 100,000 | $236,000 | 0.20% |
SPHERA FUNDS MANAGEMENT LTD. | 138,105 | $326,000 | 0.08% |
Soros Fund Management | 1,462,122 | $3,451,000 | 0.07% |
SABBY MANAGEMENT, LLC | 270,000 | $637,000 | 0.03% |
CAMBRIDGE TRUST CO | 65,414 | $154,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 30,000 | $71,000 | 0.01% |
ROYCE & ASSOCIATES LP | 376,321 | $888,000 | 0.01% |